Helicobacter pylori and antibiotic resistance.
作者信息
Megraud Francis
机构信息
Laboratoire de Bacteriologie, CHU Pellegrin, 33076 Bordeaux cedex, France.
出版信息
Gut. 2007 Nov;56(11):1502. doi: 10.1136/gut.2007.132514.
Abstract
摘要
相似文献
1
Helicobacter pylori and antibiotic resistance.
Gut. 2007 Nov;56(11):1502. doi: 10.1136/gut.2007.132514.
2
Short term increase in neuropsychiatric events is seen with H pylori treatment containing clarithromycin.
BMJ. 2016 May 2;353:i2481. doi: 10.1136/bmj.i2481.
3
Summaries for patients. Past antibiotic use affects resistance and outcomes of Helicobacter pylori infection.
Ann Intern Med. 2003 Sep 16;139(6):I10. doi: 10.7326/0003-4819-139-6-200309160-00001.
4
Can sequential therapy for Helicobacter pylori eradication overcome clarithromycin resistance?: Data still do not support conclusions.
Am J Gastroenterol. 2010 Jul;105(7):1674-5; author reply 1675. doi: 10.1038/ajg.2010.131.
5
Efficacy of Lansap combination therapy for eradication of H. pylori.
Helicobacter. 2007 Dec;12(6):643-4. doi: 10.1111/j.1523-5378.2007.00555.x.
6
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance].
Dtsch Med Wochenschr. 2013 Mar;138(13):628. doi: 10.1055/s-0032-1329041. Epub 2013 Mar 19.
7
High frequency of metronidazole and clarithromycin-resistant Helicobacter pylori in formalin-fixed, paraffin-embedded gastric biopsies.
Br J Biomed Sci. 2018 Apr;75(2):61-65. doi: 10.1080/09674845.2017.1391466. Epub 2018 Feb 16.
8
[Resistance of Helicobacter pylori to clarithomycin].
Ugeskr Laeger. 1998 Jun 1;160(23):3412-3.
9
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
Gut. 2010 Nov;59(11):1465-70. doi: 10.1136/gut.2010.215350.
10
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Z Gastroenterol. 1995 Oct;33(10):621-3.
引用本文的文献
1
Sequential versus Standard Triple Therapy for First-Line Eradication: An Update.
Antibiotics (Basel). 2024 Jan 30;13(2):136. doi: 10.3390/antibiotics13020136.
2
Evaluation of antibiotic resistance of Helicobacter pylori bacteria obtained from gastric biopsy samples: A cohort study.
Ann Med Surg (Lond). 2022 May 18;78:103824. doi: 10.1016/j.amsu.2022.103824. eCollection 2022 Jun.
3
Antibiotic Resistance of Helicobacter pylori Isolated from Patients after Partial Gastrectomy: A Retrospective Study.
Turk J Gastroenterol. 2021 Dec;32(12):996-1002. doi: 10.5152/tjg.2020.19354.
4
Influence of Genotype on Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis.
Front Pharmacol. 2021 Oct 15;12:759249. doi: 10.3389/fphar.2021.759249. eCollection 2021.
5
Periodontal Treatment Is Associated With Improvement in Gastric Helicobacter pylori Eradication: An Updated Meta-analysis of Clinical Trials.
Int Dent J. 2021 Jun;71(3):188-196. doi: 10.1111/idj.12616. Epub 2021 Jan 26.
6
High Primary Antibiotic Resistance of Strains Isolated from Pediatric and Adult Patients in Poland during 2016-2018.
Antibiotics (Basel). 2020 May 2;9(5):228. doi: 10.3390/antibiotics9050228.
7
Clarithromycin Versus Metronidazole in First-Line Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis.
J Clin Med. 2020 Feb 17;9(2):543. doi: 10.3390/jcm9020543.
8
Periodontal treatment is more effective in gastric Helicobacter pylori eradication in those patients who maintain good oral hygiene.
Int Dent J. 2019 Oct;69(5):392-399. doi: 10.1111/idj.12484. Epub 2019 Apr 30.
9
Diagnosis of Using Invasive and Noninvasive Approaches.
J Pathog. 2018 May 22;2018:9064952. doi: 10.1155/2018/9064952. eCollection 2018.
10
Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Korean J Intern Med. 2019 Sep;34(5):1022-1029. doi: 10.3904/kjim.2018.054. Epub 2018 Jun 14.
本文引用的文献
1
H pylori antibiotic resistance: prevalence, importance, and advances in testing.
Gut. 2004 Sep;53(9):1374-84. doi: 10.1136/gut.2003.022111.
2
Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori.
Antimicrob Agents Chemother. 2003 Dec;47(12):3942-4. doi: 10.1128/AAC.47.12.3942-3944.2003.
3
Review article: the treatment of refractory Helicobacter pylori infection.
Aliment Pharmacol Ther. 2003 Jun 1;17(11):1333-43. doi: 10.1046/j.1365-2036.2003.01592.x.
4
Prevalence of antibiotic resistance of Helicobacter pylori isolates in Estonia during 1995-2000 in comparison to the consumption of antibiotics used in treatment regimens.
Clin Microbiol Infect. 2002 Sep;8(9):598-603. doi: 10.1046/j.1469-0691.2002.00409.x.
5
The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001).
Helicobacter. 2002 Oct;7(5):327-8. doi: 10.1046/j.1523-5378.2002.00101_1.x.
6
The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.
Helicobacter. 2002 Oct;7(5):306-9. doi: 10.1046/j.1523-5378.2002.00096.x.
7
Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
Eur J Clin Microbiol Infect Dis. 2002 Jul;21(7):549-52. doi: 10.1007/s10096-002-0757-6. Epub 2002 Jun 28.
8
[Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment].
Enferm Infecc Microbiol Clin. 2002 Apr;20(4):157-60. doi: 10.1016/s0213-005x(02)72778-x.
9
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Aliment Pharmacol Ther. 2002 Feb;16(2):167-80. doi: 10.1046/j.1365-2036.2002.01169.x.
10
European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori.
Eur J Clin Microbiol Infect Dis. 2001 Nov;20(11):820-3. doi: 10.1007/s100960100611.
Zotero 插件